{
  "name": "Vertex Pharmaceuticals",
  "slug": "vertex-pharmaceuticals",
  "ticker": "VRTX",
  "fetched_at": "2026-02-15T12:29:01.317497+00:00",
  "news": [
    {
      "title": "Is Vertex Pharmaceuticals (VRTX) Still Attractive After Strong Multi Year Share Price Gains - simplywall.st",
      "link": "https://news.google.com/rss/articles/CBMi7AFBVV95cUxPcndDejhhWndXSjRfWkN1cFBjUkFhRkRaeTNUVHN0VEZIZU43QjQ2SFUxTWpWWjhua3BDMXJkcVdYSjdHRmhiUjdwTHNhUTZleGtsR2RGUkFqMUM1ZkFUR2F1aDZDMGZGZk1WakZIeUN4dTNfbzk1OWtBOThQSjk1SjRtc3VLZlNJQ0ZTZm9MZUt6STNnMTVoczVrVzVLTzkzZmxBajRJQlVVWlI4QzI2NEFtMmpyZVRLLUdmT0QzLUUwMU1DU3RQdWFCY1g5VGRVeU1GbkdlTlRIMC13Qm40S2xJc0Fod2xVRGVBOA?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi7AFBVV95cUxPcndDejhhWndXSjRfWkN1cFBjUkFhRkRaeTNUVHN0VEZIZU43QjQ2SFUxTWpWWjhua3BDMXJkcVdYSjdHRmhiUjdwTHNhUTZleGtsR2RGUkFqMUM1ZkFUR2F1aDZDMGZGZk1WakZIeUN4dTNfbzk1OWtBOThQSjk1SjRtc3VLZlNJQ0ZTZm9MZUt6STNnMTVoczVrVzVLTzkzZmxBajRJQlVVWlI4QzI2NEFtMmpyZVRLLUdmT0QzLUUwMU1DU3RQdWFCY1g5VGRVeU1GbkdlTlRIMC13Qm40S2xJc0Fod2xVRGVBOA?oc=5\" target=\"_blank\">Is Vertex Pharmaceuticals (VRTX) Still Attractive After Strong Multi Year Share Price Gains</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">simplywall.st</font>",
      "published": "2026-02-14T22:28:52+00:00",
      "source": "simplywall.st"
    },
    {
      "title": "Vertex Pharmaceuticals Incorporated $VRTX Shares Purchased by Aberdeen Group plc - MarketBeat",
      "link": "https://news.google.com/rss/articles/CBMi1wFBVV95cUxOY25kVEZzMzJlTFRHWEZzLVpCRmN6akJfNDJlNHAzdnRyeGQyOVBSVlNGbDFEQ3Zoa0ctUXU3OGQyTVc4ZUNEejV6UHZINjIwY1J5UEJodktkNGdRbEFsNUphUUd5MFlQWnRXdEFlckMwaDFLTHhPajcxb192d0FmUFdVaWs3WnE4cHBEaUJSQmpXWDljdmtBR3VwdmlEalIxdFY0VExIYXUyT0lhUXBqZ1pBLWFlUFhZMjNIYnA4RklJQ013bXExT3dGak1SNm9mZnhfT0JySQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi1wFBVV95cUxOY25kVEZzMzJlTFRHWEZzLVpCRmN6akJfNDJlNHAzdnRyeGQyOVBSVlNGbDFEQ3Zoa0ctUXU3OGQyTVc4ZUNEejV6UHZINjIwY1J5UEJodktkNGdRbEFsNUphUUd5MFlQWnRXdEFlckMwaDFLTHhPajcxb192d0FmUFdVaWs3WnE4cHBEaUJSQmpXWDljdmtBR3VwdmlEalIxdFY0VExIYXUyT0lhUXBqZ1pBLWFlUFhZMjNIYnA4RklJQ013bXExT3dGak1SNm9mZnhfT0JySQ?oc=5\" target=\"_blank\">Vertex Pharmaceuticals Incorporated $VRTX Shares Purchased by Aberdeen Group plc</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MarketBeat</font>",
      "published": "2026-02-15T08:27:09+00:00",
      "source": "MarketBeat"
    },
    {
      "title": "Vertex Autoimmune Deal With WuXi Adds New Angle To VRTX Valuation Story - Yahoo! Finance Canada",
      "link": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxNSl9iQTd3SXN3V3RXbWVDa1Jvai1PdWdDX2NyZFo1VGdGZHplTDY0YkRUSGh5ZHlBaWxLQnYxNUo1MFdObHRtQURLUTR0Sk45UUpJMzZxamF6bzcxMWY4Y01vMzEtQUNWS3NuSGpaczRJSFVmZDF3ZlpwemVocEJXVDFUa1Y5TVpP?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiiAFBVV95cUxNSl9iQTd3SXN3V3RXbWVDa1Jvai1PdWdDX2NyZFo1VGdGZHplTDY0YkRUSGh5ZHlBaWxLQnYxNUo1MFdObHRtQURLUTR0Sk45UUpJMzZxamF6bzcxMWY4Y01vMzEtQUNWS3NuSGpaczRJSFVmZDF3ZlpwemVocEJXVDFUa1Y5TVpP?oc=5\" target=\"_blank\">Vertex Autoimmune Deal With WuXi Adds New Angle To VRTX Valuation Story</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo! Finance Canada</font>",
      "published": "2026-02-15T06:09:00+00:00",
      "source": "Yahoo! Finance Canada"
    },
    {
      "title": "Oppenheimer Upgrades Vertex Pharmaceuticals (VRTX) - Nasdaq",
      "link": "https://news.google.com/rss/articles/CBMihwFBVV95cUxPWmJNYzdJQ1VvUEcwc2p4SHY5Z2dwU0JyLXBPWnpoNXp2RFdRTURtaUI1amh1LUJPVjExcmk0SE53LWlUUXRpNnY3dVJzQm85RzhRQWdJWC0wd2dTalRSenBmZXptRzFpcHV1SWU5ZGJCdGRfcEhJT2NFdmJ1X2Z6WDJwWkh1RWM?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMihwFBVV95cUxPWmJNYzdJQ1VvUEcwc2p4SHY5Z2dwU0JyLXBPWnpoNXp2RFdRTURtaUI1amh1LUJPVjExcmk0SE53LWlUUXRpNnY3dVJzQm85RzhRQWdJWC0wd2dTalRSenBmZXptRzFpcHV1SWU5ZGJCdGRfcEhJT2NFdmJ1X2Z6WDJwWkh1RWM?oc=5\" target=\"_blank\">Oppenheimer Upgrades Vertex Pharmaceuticals (VRTX)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Nasdaq</font>",
      "published": "2026-02-13T20:02:00+00:00",
      "source": "Nasdaq"
    },
    {
      "title": "Busy with Casgevy and Journavx launches, Vertex sets ambitious $500M revenue goal for non-CF meds this year - Fierce Pharma",
      "link": "https://news.google.com/rss/articles/CBMivwFBVV95cUxQdkt0aXdsbHpVeTg1NHBENGJEUk1yZVphcDU0MHhkYWRLZGVBd2J0WlJOaWt0WVlOeUVJWmFvbkQ5UXB5S2dGUzBYUW1YeUtwSm1WY1poMlMzREp0V0F3WG1ydzVLVFhobzlBWGNab1ltWjZfVnIzSm41WmtPeFdoR196MkxlRW1hTWs2U1p0MzF3a285SmhpM3BoUkNVQW1Zb0xCUFczZHpqaGFKbHdqYjFoS0JQZUtHVXdfYlRSQQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivwFBVV95cUxQdkt0aXdsbHpVeTg1NHBENGJEUk1yZVphcDU0MHhkYWRLZGVBd2J0WlJOaWt0WVlOeUVJWmFvbkQ5UXB5S2dGUzBYUW1YeUtwSm1WY1poMlMzREp0V0F3WG1ydzVLVFhobzlBWGNab1ltWjZfVnIzSm41WmtPeFdoR196MkxlRW1hTWs2U1p0MzF3a285SmhpM3BoUkNVQW1Zb0xCUFczZHpqaGFKbHdqYjFoS0JQZUtHVXdfYlRSQQ?oc=5\" target=\"_blank\">Busy with Casgevy and Journavx launches, Vertex sets ambitious $500M revenue goal for non-CF meds this year</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Fierce Pharma</font>",
      "published": "2026-02-13T17:02:15+00:00",
      "source": "Fierce Pharma"
    },
    {
      "title": "Should You Buy Vertex Pharmaceuticals Before Feb. 12? - The Motley Fool",
      "link": "https://news.google.com/rss/articles/CBMimAFBVV95cUxQMnVCNUl1WVk1MHp2cGxaSHdlZUt2NGNfcTl3Q2o4by04X2hXUkRiR0NTbi1JQmdmTTk3VFppcWZYU2VSUG1uTlYyNlhfVjhHMmY1NUVCOGNPWlp0M2czLTE0alBsRjAyalBSN2RxYklDWU9SbFFkX3NsaDhodDBrcmRfSXcwbVpobmpMR2pUZmIwamltWUVTTw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMimAFBVV95cUxQMnVCNUl1WVk1MHp2cGxaSHdlZUt2NGNfcTl3Q2o4by04X2hXUkRiR0NTbi1JQmdmTTk3VFppcWZYU2VSUG1uTlYyNlhfVjhHMmY1NUVCOGNPWlp0M2czLTE0alBsRjAyalBSN2RxYklDWU9SbFFkX3NsaDhodDBrcmRfSXcwbVpobmpMR2pUZmIwamltWUVTTw?oc=5\" target=\"_blank\">Should You Buy Vertex Pharmaceuticals Before Feb. 12?</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Motley Fool</font>",
      "published": "2026-02-09T18:46:00+00:00",
      "source": "The Motley Fool"
    },
    {
      "title": "Vertex Pharma Q4 2025 Earnings Results - AlphaStreet News",
      "link": "https://news.google.com/rss/articles/CBMid0FVX3lxTE9HY1RFaF9ZZjY1ZzE0S1NxMWhySzJPSjZ1NVZ0YUM3SEVqTTc4TDgxbXIzVzVmLXU0Z0lfZG00RFB6dUhUVHZrM2lVZ0xqUmN1YVNLUUhzUW82RGRTZnNVZkotYlNUbnBXdFFhVDdoM2ZvNVNhbi000gF8QVVfeXFMTWQ2SFBEeUppQlgxWEN0aV9nSzBhSDhybjBpZUdndmEyZmpOZXVFc3FUa0U4XzRFb3F5ZFJwc01PdE1xUFlmUDlpdlotTGozX0FzN0ZfMGkxUGc2Tmg4RnBXZUpZek9fQVp2bjFJVVI0Z3F3aTFMTjJ1enYzbQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMid0FVX3lxTE9HY1RFaF9ZZjY1ZzE0S1NxMWhySzJPSjZ1NVZ0YUM3SEVqTTc4TDgxbXIzVzVmLXU0Z0lfZG00RFB6dUhUVHZrM2lVZ0xqUmN1YVNLUUhzUW82RGRTZnNVZkotYlNUbnBXdFFhVDdoM2ZvNVNhbi000gF8QVVfeXFMTWQ2SFBEeUppQlgxWEN0aV9nSzBhSDhybjBpZUdndmEyZmpOZXVFc3FUa0U4XzRFb3F5ZFJwc01PdE1xUFlmUDlpdlotTGozX0FzN0ZfMGkxUGc2Tmg4RnBXZUpZek9fQVp2bjFJVVI0Z3F3aTFMTjJ1enYzbQ?oc=5\" target=\"_blank\">Vertex Pharma Q4 2025 Earnings Results</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">AlphaStreet News</font>",
      "published": "2026-02-13T13:13:22+00:00",
      "source": "AlphaStreet News"
    },
    {
      "title": "Vertex Pharmaceuticals Signals Confident Growth Beyond CF - TipRanks",
      "link": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNT0w3TjFuQzV1MFdhOE83X2c4Nnh4aHI2VXJvU1pvT0F3QVY2TWx5M1IzZmFsMV80YW9LX1VKQjBRdl90MTBRVnJoajNNaGNCRkZ1OWJONnczQTRqQjdoQVp0TUhxSmZ1LWhXSVdUSHg1c3hscVdEYkFqQzVKWlpCNlVSZk5OY3pFc2xlckVod2tWZ3pIVC1DQnBsd2FmREpReFEzRzdyME43eWlzWXc?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMirgFBVV95cUxNT0w3TjFuQzV1MFdhOE83X2c4Nnh4aHI2VXJvU1pvT0F3QVY2TWx5M1IzZmFsMV80YW9LX1VKQjBRdl90MTBRVnJoajNNaGNCRkZ1OWJONnczQTRqQjdoQVp0TUhxSmZ1LWhXSVdUSHg1c3hscVdEYkFqQzVKWlpCNlVSZk5OY3pFc2xlckVod2tWZ3pIVC1DQnBsd2FmREpReFEzRzdyME43eWlzWXc?oc=5\" target=\"_blank\">Vertex Pharmaceuticals Signals Confident Growth Beyond CF</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TipRanks</font>",
      "published": "2026-02-14T00:05:23+00:00",
      "source": "TipRanks"
    }
  ],
  "product_launches": [
    {
      "title": "Busy with Casgevy and Journavx launches, Vertex sets ambitious $500M revenue goal for non-CF meds this year - Fierce Pharma",
      "link": "https://news.google.com/rss/articles/CBMivwFBVV95cUxQdkt0aXdsbHpVeTg1NHBENGJEUk1yZVphcDU0MHhkYWRLZGVBd2J0WlJOaWt0WVlOeUVJWmFvbkQ5UXB5S2dGUzBYUW1YeUtwSm1WY1poMlMzREp0V0F3WG1ydzVLVFhobzlBWGNab1ltWjZfVnIzSm41WmtPeFdoR196MkxlRW1hTWs2U1p0MzF3a285SmhpM3BoUkNVQW1Zb0xCUFczZHpqaGFKbHdqYjFoS0JQZUtHVXdfYlRSQQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivwFBVV95cUxQdkt0aXdsbHpVeTg1NHBENGJEUk1yZVphcDU0MHhkYWRLZGVBd2J0WlJOaWt0WVlOeUVJWmFvbkQ5UXB5S2dGUzBYUW1YeUtwSm1WY1poMlMzREp0V0F3WG1ydzVLVFhobzlBWGNab1ltWjZfVnIzSm41WmtPeFdoR196MkxlRW1hTWs2U1p0MzF3a285SmhpM3BoUkNVQW1Zb0xCUFczZHpqaGFKbHdqYjFoS0JQZUtHVXdfYlRSQQ?oc=5\" target=\"_blank\">Busy with Casgevy and Journavx launches, Vertex sets ambitious $500M revenue goal for non-CF meds this year</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Fierce Pharma</font>",
      "published": "2026-02-13T17:02:15+00:00",
      "source": "Fierce Pharma"
    },
    {
      "title": "Vertex Pharmaceuticals Inc (VRTX) Q4 2025 Earnings Call Highligh - GuruFocus",
      "link": "https://news.google.com/rss/articles/CBMi5AFBVV95cUxNTmtLdkUxTmFSQ19ieWxlMHp5X1dxdDFpOU1kTXVTcVN2OTJfQjE5aDZkWUdpOV9tWXBmcENfQzhaaDBsWUJ2TGgwVDlpQ1RvZXNxbEVwYUZ1THRVaXA3dXl0WWNVbDMtdjZkbGFvRE9TdnM4YVMtbFZhT0ZnNUdZc3lCOThGZFVjNGZjRGhHM0hkTExJV3dtaDFibC1MSU1IbWsxT3o5Tk15bHlIblU0TXZFQWkwSW4ya2ZQWm53ZWg4Z3Z4YmE2WDBNdVRzVFpoZUZpVV9lRzdXR3dsQUNlVnNjNXg?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi5AFBVV95cUxNTmtLdkUxTmFSQ19ieWxlMHp5X1dxdDFpOU1kTXVTcVN2OTJfQjE5aDZkWUdpOV9tWXBmcENfQzhaaDBsWUJ2TGgwVDlpQ1RvZXNxbEVwYUZ1THRVaXA3dXl0WWNVbDMtdjZkbGFvRE9TdnM4YVMtbFZhT0ZnNUdZc3lCOThGZFVjNGZjRGhHM0hkTExJV3dtaDFibC1MSU1IbWsxT3o5Tk15bHlIblU0TXZFQWkwSW4ya2ZQWm53ZWg4Z3Z4YmE2WDBNdVRzVFpoZUZpVV9lRzdXR3dsQUNlVnNjNXg?oc=5\" target=\"_blank\">Vertex Pharmaceuticals Inc (VRTX) Q4 2025 Earnings Call Highligh</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">GuruFocus</font>",
      "published": "2026-02-13T05:12:17+00:00",
      "source": "GuruFocus"
    },
    {
      "title": "Strong Product Launches and Upbeat Guidance Could Be a Game Changer for Vertex Pharmaceuticals (VRTX) - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMijgFBVV95cUxNOFZFNHZzSk1rSnJWVTEwWExLd1FvWVBPUkVkTV9TRG1oUWdTbWgzbWNkdlA3MkVLNmVra3NUUWhBQWFXZ3c5LVNxZFRkWDhkMUZ1QVlUXzg3ZEZwOHY3TTRjMEYxUjlwZFhYVW84QUVXX0lQaTZVbDN4Qk5WM1NQX0EwSVJXZ2piZXl4d3ZB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMijgFBVV95cUxNOFZFNHZzSk1rSnJWVTEwWExLd1FvWVBPUkVkTV9TRG1oUWdTbWgzbWNkdlA3MkVLNmVra3NUUWhBQWFXZ3c5LVNxZFRkWDhkMUZ1QVlUXzg3ZEZwOHY3TTRjMEYxUjlwZFhYVW84QUVXX0lQaTZVbDN4Qk5WM1NQX0EwSVJXZ2piZXl4d3ZB?oc=5\" target=\"_blank\">Strong Product Launches and Upbeat Guidance Could Be a Game Changer for Vertex Pharmaceuticals (VRTX)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-08-22T07:00:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Vertex Pharmaceuticals Reports Strong Q4 2025 Earnings and 2026 Guidance - Intellectia AI",
      "link": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxOZ0R1MTM2NDZYSFZLZE9Cc3F4bnBIRlpsb1FUcnV1VWVIUGtzY2xuTXpUN1Brc1hZWTRqVDZEcUtCM3lsZW80VFN0bkRfOUJsdk5mU2pNMWhSVGpYQjVxUmJ3RXp2aG4tVW9rVWNhZDFpQW8yeG5IdE44OEZ4VnlSV0hUTzdxN1FsVU5ES1VsOW8xVncycmpzZUkzb3YzS0NZQzZhY1phMW9Zdw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiqgFBVV95cUxOZ0R1MTM2NDZYSFZLZE9Cc3F4bnBIRlpsb1FUcnV1VWVIUGtzY2xuTXpUN1Brc1hZWTRqVDZEcUtCM3lsZW80VFN0bkRfOUJsdk5mU2pNMWhSVGpYQjVxUmJ3RXp2aG4tVW9rVWNhZDFpQW8yeG5IdE44OEZ4VnlSV0hUTzdxN1FsVU5ES1VsOW8xVncycmpzZUkzb3YzS0NZQzZhY1phMW9Zdw?oc=5\" target=\"_blank\">Vertex Pharmaceuticals Reports Strong Q4 2025 Earnings and 2026 Guidance</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Intellectia AI</font>",
      "published": "2026-02-13T04:09:50+00:00",
      "source": "Intellectia AI"
    },
    {
      "title": "Vertex’s new pain, blood disorder drugs miss Wall Street expectations - BioPharma Dive",
      "link": "https://news.google.com/rss/articles/CBMimgFBVV95cUxPSzdmS1NOZmlSUk5NZGNNbXdJdi1FajV2ZzVYQU5zaXVxVEV3RnFqNG1MUk9EMEtBT0h1Z1JpOEJsQU1Uek4wRUQtZ1dwc3NxVXlrU2dJbDdNNnplVUxrWkJzMHFreHZqUmFOYktWY2ZLLWtBV2tJZGNvSXFkdGVETXNiNkd1UHR2SFQxTmFIdktQSzFhbzc5a1BR?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMimgFBVV95cUxPSzdmS1NOZmlSUk5NZGNNbXdJdi1FajV2ZzVYQU5zaXVxVEV3RnFqNG1MUk9EMEtBT0h1Z1JpOEJsQU1Uek4wRUQtZ1dwc3NxVXlrU2dJbDdNNnplVUxrWkJzMHFreHZqUmFOYktWY2ZLLWtBV2tJZGNvSXFkdGVETXNiNkd1UHR2SFQxTmFIdktQSzFhbzc5a1BR?oc=5\" target=\"_blank\">Vertex’s new pain, blood disorder drugs miss Wall Street expectations</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BioPharma Dive</font>",
      "published": "2025-11-04T08:00:00+00:00",
      "source": "BioPharma Dive"
    }
  ],
  "stock": {
    "ticker": "VRTX",
    "currency": "USD",
    "latest": {
      "date": "2026-02-13",
      "close": 491.4700012207031
    },
    "history": [
      {
        "date": "2026-02-05",
        "close": 458.80999755859375
      },
      {
        "date": "2026-02-06",
        "close": 477.9200134277344
      },
      {
        "date": "2026-02-09",
        "close": 470.8699951171875
      },
      {
        "date": "2026-02-10",
        "close": 463.4800109863281
      },
      {
        "date": "2026-02-11",
        "close": 461.239990234375
      },
      {
        "date": "2026-02-12",
        "close": 465.0199890136719
      },
      {
        "date": "2026-02-13",
        "close": 491.4700012207031
      }
    ],
    "name": "Vertex Pharmaceuticals Incorpor"
  }
}